AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...

Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...

Greater Manchester Mayor Andy Burnham has helped open a collaborative space on a visit to officially mark a partnership ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

Two current and two former senior executives at AstraZeneca Plc are under investigation in China in an ongoing probe into ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

AstraZeneca suffered a £14bn share price hit on Tuesday after Chinese media reported more details about an investigation into ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former executives of the company.

Barclays analyst Emily Field says the selloff yesterday in shares of AstraZeneca (AZN) on a local news report that China’s investigation ...

Deutsche Bank upgraded AstraZeneca (AZN) to Hold from Sell with an unchanged price target of 10,500 GBp. The firm cites valuation for the ...